search
Back to results

AMBULAPSE STUDY Feasibility Study on Laparoscopic Double-mesh Sacrocolpopexy With or Without Robotic Assistance, in Female Patients Presenting With Symptomatic Pelvic Organ Prolapse, Based on an Outpatient Treatment Model. (AMBULAPSE)

Primary Purpose

Pelvic Organ Prolapse

Status
Unknown status
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
outpatient laparoscopic
outpatient laparoscopic
Sponsored by
Centre Hospitalier Universitaire de Nice
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pelvic Organ Prolapse focused on measuring outpatient

Eligibility Criteria

40 Years - 80 Years (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • woman between 40 and 80 years old
  • Patient with significant prolapse POP-Q ≥ 2
  • BMI <30
  • ASA score ≤ 2
  • sterile ECBU

Exclusion Criteria:

  • Criteria related to the pathology or the organ:

    • History of pelvic cancer surgery
    • History of prolapse surgery
    • History of pelvic irradiation
    • Laying a concomitant urethral strip
    • Cervico-vaginal smear test not up to date.
    • Patient pregnant or having a desire for pregnancy
  • Criteria related to concomitant treatments:

    • Cefazoline allergy
    • Taking the following medications within 48 hours
  • Plavix®
  • Vitamin K / Low Molecular Weight Healing Heparin

    • Contraindication to ambulatory care for medical reasons
  • Sleep apnea syndrome
  • Cardiopulmonary pathology
  • Psychiatric pathology
  • Hemorrhagic risk
  • Diabetes imbalanced
  • Unbalanced Hypertension

Sites / Locations

  • Hopital Antoine Beclere - AphpRecruiting
  • Chu de NantesRecruiting
  • CHU DE Nice - Hôpital l'ArchetRecruiting
  • Ch Lyon SudRecruiting
  • Hopital FochRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

outpatient laparoscopic

Arm Description

Patients will have laparoscopic outpatients. The procedure is identical to that performed in hospital. What changes is that the patient will return home at night if her condition allows it.

Outcomes

Primary Outcome Measures

Successful outpatient treatment
Successful outpatient treatment is defined by the absence of conventional inpatient admission with 24H after surgery, the indications for admission being a CHUNG Score < 9, one perioperative complication, postoperative urinary retention requiring reinsertion of a urinary catheter

Secondary Outcome Measures

The percentage of failure of the outpatient
The percentage of failure of the outpatient is defined by the number of patients with a CHUNG score <9 in the outpatient department that does not allow the discharge of the patient or her admission to conventional hospitalization.

Full Information

First Posted
December 3, 2018
Last Updated
February 7, 2020
Sponsor
Centre Hospitalier Universitaire de Nice
search

1. Study Identification

Unique Protocol Identification Number
NCT03764852
Brief Title
AMBULAPSE STUDY Feasibility Study on Laparoscopic Double-mesh Sacrocolpopexy With or Without Robotic Assistance, in Female Patients Presenting With Symptomatic Pelvic Organ Prolapse, Based on an Outpatient Treatment Model.
Acronym
AMBULAPSE
Official Title
Feasibility Study on Laparoscopic Double-mesh Sacrocolpopexy With or Without Robotic Assistance, in Female Patients Presenting With Symptomatic Pelvic Organ Prolapse, Based on an Outpatient Treatment Model.
Study Type
Interventional

2. Study Status

Record Verification Date
February 2020
Overall Recruitment Status
Unknown status
Study Start Date
December 14, 2019 (Actual)
Primary Completion Date
January 2021 (Anticipated)
Study Completion Date
January 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre Hospitalier Universitaire de Nice

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Pelvic organ prolapse is an increasingly common functional disorder which affects approximately 30 to 40% of the female population, 12% of whom have a symptomatic form, with a psychological, physical and social impact. Laparoscopic sacrocolpopexy represents the surgical "gold standard" for the treatment of this functional disorder. It aims to suspend the vaginal vault by means of a prosthesis. The patient satisfaction rate is evaluated at 94% with low overall complication rate, evaluated at 11%. Pelvic organ prolapse surgery is a common, with an estimated 30,000 procedures carried out in France in 2013 (excluding hysterectomy) (2013 ATIH data), and the number will increase in the future due to increasing life expectancy. 13% of women will undergo this type of procedure. The French General Directorate of Health Care Supply (DGOS) deems outpatient surgery to be the benchmark for surgical activity in all eligible patients, and has expressed the need for recommendations and tools for supporting its development. The rate of outpatient surgery for prolapse remains low in France (6.1%, 2015 ATIH data), while it is 25% in the US and 56% in Denmark. The average duration of hospital stays for DRG N81.2 (first degree uterine prolapse) in 2015 was 3.43 days. These procedures have been the subject of publications concerning outpatient care and involving low numbers of patients, with the exception of the publication by Sinhal which involved 111 patients.
Detailed Description
In our study, the investigators propose to evaluate the success rate for outpatient laparoscopic sacrocolpopexy with or without robotic assistance in screened patients. With this aim in mind, the investigators will conduct a national multicenter prospective study including 80 female patients. Successful outpatient treatment is defined by the absence of conventional inpatient admission with 24H after surgery, the indications for admission being a CHUNG Score < 9, one perioperative complication, postoperative urinary retention requiring reinsertion of a urinary catheter. The outpatient success rate for other surgical techniques such as cholecystectomy or laparoscopic hysterectomy is above 90% in the literature. Envisaging an equivalent rate after laparoscopic sacrocolpopexy, our population size would make it possible to obtain precision +/- 5.3% for estimation of this proportion. The patients are followed up for 1 month with a postoperative visit at 30 days, during which the efficacy of the technique is evaluated using conventional indicators (POP-Q; ICIQ, USP, PFDI-20, PISQ-12, PFIQ-7, etc.). Once completed, this preliminary investigation will make it possible to define a reference value for successful outpatient sacrocolpopexy, which has not yet been published, which may be used as a basis for a larger scale randomized study that would aim to compare the efficacy of outpatient treatment, with conventional inpatient treatment, for efficient patient management

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pelvic Organ Prolapse
Keywords
outpatient

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
80 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
outpatient laparoscopic
Arm Type
Experimental
Arm Description
Patients will have laparoscopic outpatients. The procedure is identical to that performed in hospital. What changes is that the patient will return home at night if her condition allows it.
Intervention Type
Procedure
Intervention Name(s)
outpatient laparoscopic
Intervention Description
The intervention is a outpatient laparoscopic sacrocolpopexy with robotic assistance.
Intervention Type
Procedure
Intervention Name(s)
outpatient laparoscopic
Intervention Description
The intervention is a outpatient laparoscopic sacrocolpopexy without robotic assistance.
Primary Outcome Measure Information:
Title
Successful outpatient treatment
Description
Successful outpatient treatment is defined by the absence of conventional inpatient admission with 24H after surgery, the indications for admission being a CHUNG Score < 9, one perioperative complication, postoperative urinary retention requiring reinsertion of a urinary catheter
Time Frame
24 hours after surgery
Secondary Outcome Measure Information:
Title
The percentage of failure of the outpatient
Description
The percentage of failure of the outpatient is defined by the number of patients with a CHUNG score <9 in the outpatient department that does not allow the discharge of the patient or her admission to conventional hospitalization.
Time Frame
24 hours after surgery

10. Eligibility

Sex
Female
Gender Based
Yes
Gender Eligibility Description
Only woman with pelvic organ prolapse
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: woman between 40 and 80 years old Patient with significant prolapse POP-Q ≥ 2 BMI <30 ASA score ≤ 2 sterile ECBU Exclusion Criteria: Criteria related to the pathology or the organ: History of pelvic cancer surgery History of prolapse surgery History of pelvic irradiation Laying a concomitant urethral strip Cervico-vaginal smear test not up to date. Patient pregnant or having a desire for pregnancy Criteria related to concomitant treatments: Cefazoline allergy Taking the following medications within 48 hours Plavix® Vitamin K / Low Molecular Weight Healing Heparin Contraindication to ambulatory care for medical reasons Sleep apnea syndrome Cardiopulmonary pathology Psychiatric pathology Hemorrhagic risk Diabetes imbalanced Unbalanced Hypertension
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Brannwel TIBI, MD
Phone
0492037849
Email
tibi.b@chu-nice.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Matthieu DURAND, MD
Phone
0492037849
Email
durand.m@chu-nice.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Brannwel TIBI, MD
Organizational Affiliation
Centre Hospitalier Universitaire de Nice
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hopital Antoine Beclere - Aphp
City
Clamart
ZIP/Postal Code
92140
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Xavier DEFFIEUX, MD
Facility Name
Chu de Nantes
City
Nantes
ZIP/Postal Code
44093
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Marie-Aimée PERROUIN-VERBE, MD
Facility Name
CHU DE Nice - Hôpital l'Archet
City
Nice
ZIP/Postal Code
06200
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Maxence DOREZ, MD
Email
dorez.m@chu-nice.fr
Facility Name
Ch Lyon Sud
City
Pierre-Bénite
ZIP/Postal Code
69310
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Alain RUFFION, MD, PhD
Facility Name
Hopital Foch
City
Suresnes
ZIP/Postal Code
92150
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Adrien VIDART, MD

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
24365629
Citation
Drapier E, De Poncheville L, Dannappel T, Clerc P, Smirnoff A. [Day case laparoscopic sacral colpopexy for genital prolapse]. Prog Urol. 2014 Jan;24(1):51-6. doi: 10.1016/j.purol.2013.07.007. Epub 2013 Aug 13. French.
Results Reference
background
PubMed Identifier
9921553
Citation
Bump RC, Norton PA. Epidemiology and natural history of pelvic floor dysfunction. Obstet Gynecol Clin North Am. 1998 Dec;25(4):723-46. doi: 10.1016/s0889-8545(05)70039-5.
Results Reference
background
PubMed Identifier
17370026
Citation
Flam F. Sedation and local anaesthesia for vaginal pelvic floor repair of genital prolapse using mesh. Int Urogynecol J Pelvic Floor Dysfunct. 2007 Dec;18(12):1471-5. doi: 10.1007/s00192-007-0350-8. Epub 2007 Mar 17.
Results Reference
result
PubMed Identifier
23721700
Citation
Cuvelier G. [The ambulatory surgery, source of publications]. Prog Urol. 2013 Jun;23(7):427-9. doi: 10.1016/j.purol.2013.02.007. Epub 2013 Mar 26. No abstract available. French.
Results Reference
result

Learn more about this trial

AMBULAPSE STUDY Feasibility Study on Laparoscopic Double-mesh Sacrocolpopexy With or Without Robotic Assistance, in Female Patients Presenting With Symptomatic Pelvic Organ Prolapse, Based on an Outpatient Treatment Model.

We'll reach out to this number within 24 hrs